Institute for International Research

Know how to achieve

Main menu

My IIR

Login form

Sign Up

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200



Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Watch for Changes

Receive email when this page changes

Genotoxic Impurities Genotoxic Impurities

December 08 - 09, 2008 | The Inn at Penn, Philadelphia, PA

Event Overview

Event Overview

Comprehensive Answers to You Most Pressing GTI Challenges to Think Ahead:
  • Regulatory Experiences: Hear current FDA and EU experiences to understand how to implement the EU Guidance
    • Dr. Roland Froetschl, Genetic Toxicology. Federal Institute for Drugs and Medical Devices, BfArM, Germany
  • Toxicology: Tools to assess Genotoxic Impurities and interpret the results
  • Analytical Chemistry/CMC: Understand the methods and techniques to analyze and contain low level of impurities
  • Process Chemistry/Quality Assurance: How to avoid and get rid of Genotoxic Impurities

Prepare Now! Take this Opportunity to:

  • Compare the PhRMA, ICH, and EU papers and guidance
  • Hear strategies for navigating the FDA GTI processes
  • Understand toxicological perspective of risk assessment
  • Explore the concept of Threshold of Toxicological Concern (TTC) to learn how regulators and industry are tackling this challenge
  • Discover analytical approaches and chemical processes for understanding GTIs
  • Discuss a risk-based approach for controlling GTIs
  • Learn the structure determination and assessment of GTIs from forced degradation products
  • Gain new prediction tools of degradation pathways and GTIs

Event Sponsors

  • Lhasa Limited

Add Event To Calendar

Save the event dates in your Outlook calendar

Registration

Online Registration is open!

Find another IIR Event

Event Search Form by Industry

Bottom menu

Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved

Powered by Interactive Agency Janmedia Interactive, Inc.